Role of Clusterin/NF-κB in the secretion of senescence-associated secretory phenotype in Cr(VI)-induced premature senescent L-02 hepatocytes

• Published in: Ecotoxicology and environmental safety 2021-08, Vol.219, p.112343-112343, Article 112343
• Main Authors: Liang, Yuehui, Liang, Ningjuan, Ma, Yu, Tang, Sixuan, Ye, Shuzi, Xiao, Fang
• Format: Article
• Language: English
• Subjects: Clusterin; Hexavalent chromium [Cr(VI)]; Nuclear factor-kappa B (NF-κB); Premature senescence; Senescence-associated secretory phenotype (SASP)
• ISSN: 0147-6513; 1090-2414
• DOI: 10.1016/j.ecoenv.2021.112343

Hexavalent chromium [Cr(VI)] and its compounds have caused serious environmental pollution and health damage. Senescent cells can actively change the surrounding environment by secreting some factors, which are called senescence associated secretory phenotype (SASP). Our previous work has confirmed that premature senescent hepatocytes induced by Cr(VI) expressed high level of Clusterin (CLU) and secrete interleukin-6 (IL-6) and IL-8. CLU is involved in the regulation of tumor development and drug resistance, but whether CLU regulates SASP components and participates in Cr(VI)-induced malignant transformation is unclear. In this study we demonstrated that Cr(VI) induced the secretion of tumor promoting components of SASP such as IL-6, IL-8, and granulocyte-macrophage colony stimulating factor (GM-CSF) in senescent L-02 hepatocytes, while the levels of the anti-tumor components of SASP such as chemokine (c-x-c motif) ligand-1 (CXCL-1) and monocyte chemoattractant protein-1 (MCP-1) were not altered. CLU shRNA interference significantly reduced the levels of IL-6, IL-8, and GM-CSF in the culture medium of senescent cells, suggesting CLU may regulate SASP. The NF-κB inhibitor PDTC significantly alleviated Cr(VI)-induced increase of IL-6, IL-8, and GM-CSF, confirming that NF-κB can regulate the tumor promoting components of SASP. CLU shRNA interference aggravated the inhibitory effect of PDTC on SASP secretion, indicating that CLU regulated the secretion of SASP in Cr(VI)-induced senescent hepatocytes through the NF-κB signaling. We speculated that SASP secreted by Cr(VI)-induced premature senescent hepatocytes was tightly related to the carcinogenic effect of Cr(VI). Therefore, elucidation of upstream regulatory mechanism of SASP is of great significance. In addition to further clarifying the carcinogenic mechanisms associated with Cr(VI), we could also seek out new targets for treatment of Cr(VI)-related cancer. •Cr(VI) induced the secretion of SASP in senescent L-02 hepatocytes.•Cr(VI)-induced secretion of SASP was associated with high expression of CLU.•NF-κB played a role in Cr(VI)-induced secretion of SASP in L-02 senescent cells.•CLU regulated the secretion of SASP through the NF-κB signaling pathway.